-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $5

Benzinga·08/11/2026 20:07:59
Listen to the news
Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $4 to $5.